+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 19Years - 84Years
All Genders
ID05320926

Comparing Clopidogrel and Aspirin Alone After 1-3 Months of Dual-Antiplatelet Therapy Following Zotarolimus-Eluting Onyx Stent Placement for Ischemic Heart Disease

Led by Yonsei University · Updated on 2024-10-22

3744

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating which single antiplatelet medication is best to maintain after a short period of dual antiplatelet therapy DAPT following percutaneous coronary intervention PCI with zotarolimus-eluting Onyx stents in patients with ischemic heart disease. The study compares clopidogrel monotherapy to aspirin monotherapy after 1 to 3 months of DAPT, aiming to determine which option better reduces adverse clinical events over one year. This trial considers patient bleeding risk, clinical presentation, and lesion complexity for treatment duration decisions. Participants will receive 1 to 3 months of DAPT after stent placement, with the duration set as 1 month for high bleeding risk patients and 3 months for others with unstable angina or complex lesions. After this period, patients will be randomly assigned to continue with either clopidogrel alone or aspirin alone. Randomization is stratified based on bleeding risk, clinical condition, and lesion complexity to ensure balanced groups. During the study, participants will be monitored for net adverse clinical events, including heart-related complications, stroke, and stent issues, over 12 months following the procedure. Researchers will track these outcomes through regular assessments. The total duration of participation includes the initial DAPT period plus one year of follow-up to evaluate safety and efficacy measures.

CONDITIONS

Brief Title

Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

Research Team

B

Byeong-Keuk Kim

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here